Searched for
NOVARTIS DRUG
Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...- Novartis experimental actinium-based drug shows promise in prostate cancer treatment: StudyNovartis' new experimental actinium-based drug shows promise against prostate cancer. Early data on Sunday revealed anti-tumour activity, e...
- Molecule glue drugs shake up cancer care, draw big moneyHarvard-born idea doubles survival in trials, triggers pharma frenzy as cos race to target 'undruggable' proteins with next-gen glue therap...
- Alzheimer's a key part of Eli Lilly's India specialty medicine push, says company's country head Winselow TuckerEli Lilly has introduced Lormalzi in India, a pioneering treatment for Alzheimer's that specifically targets amyloid plaques, a significant...
- DeepMind CEO Demis Hassabis’ Isomorphic Labs raises $2.1 billion led by Thrive CapitalAI-driven drug discovery firm Isomorphic Labs secured a massive $2.1 billion in Series B funding. This capital will fuel the expansion of t...
- Google’s Isomorphic Labs to raise over $2 billion in new fundingAlphabet's AI drug discovery firm, Isomorphic Labs, is reportedly close to securing over $2 billion in new funding, led by Thrive Capital. ...
- ‘The count is up to 13’: Congressman presses FBI over Matthew Sullivan’s suspicious death in missing scientists mysteryRep. Eric Burlison is demanding answers from the FBI regarding the suspicious deaths and disappearances of at least 13 American scientists ...
- Anthropic appoints Indian-origin Novartis CEO Vas Narasimhan to its boardAnthropic’s Long-Term Benefit Trust is an independent governance body, designed to insulate key decisions as it scales its frontier AI syst...
- US Stocks: Biogen gets FDA approval for higher dose of genetic disorder drug, shares rise 3%The U.S. Food and Drug Administration has approved a higher dose of Biogen's spinal muscular atrophy drug Spinraza, the company said on M...
- Novartis to buy experimental breast cancer drug in up to $3 billion dealSwiss drugmaker Novartis is set to acquire a promising breast cancer drug candidate from US biotech firm Synnovation Therapeutics. The deal...
- Novartis case: Delhi HC pulls up patent office over decade-long delay in breast cancer drug approvalThe Delhi High Court has stepped in with a firm hand, criticizing the patent office for its sluggish response to Novartis AG's 2011 patent ...
- Natco Plea: Delhi high court sets aside Novartis patentNatco filed writ petition citing procedural irregularities and violation of principles of natural justice by the Assistant Controller of Pa...
- Novartis pays $678 million to resolve suit over sham doctor outingsThe settlement of the lawsuit was announced by Acting Manhattan U.S. Attorney Audrey Strauss, who said the company splurged on "speaking fe...
- Lupin, Cipla, other top drugmakers in fray for Novartis’ brandsThe Novartis portfolio includes top-selling brand TOBI Podhaler, a drug prescribed for symptomatic relief to patients suffering from cystic...
- Delhi High Court upholds ruling barring Cipla from selling copies of Novartis drugAccording to the judgment, Cipla had claimed that 10 tablets of Onbrez cost Rs 677 as opposed to its own drug priced at Rs 130.
- Ready to pay "reasonable" royalty to Novartis AG: Cipla to HCCipla was making submission for lifting the stay ordered by a single judge bench restraining it from manufacturing the drug.
- Delhi High Court notice to Novartis on Cipla plea"We will not give you an interim order. We will hear it on an early date and dispose it of. Notice. Renotify on February 5," the bench said.
- Novartis may be fined for submitting ‘fake’ document to Drug Controller General of IndiaNovartis may face penalties in India for submitting 'fake' document to the Drug Controller General of India (DCGI) for a veterinary medicin...
- Novartis sales team involved in bribing stockists for over a yearStockists had complained that Novartis' sales representatives had been offering massive discounts in order to push sales.
- SC ruling on Novartis victory of humanity over commercial consideration: Bhaskar Narayana, Natco PharmaNovartis has been selling it at international prices all over the world and whatever price it sells in the US, it sells at the same price i...
Load More
